UK
Addenbrooke’s hospital offers first self-service digital eye test
July 17, 2025Research and Development Addenbrooke's Hospital, Cambridge, Opthalmology, UK, eye test, ophthalmology
Addenbrooke’s Hospital, Cambridge, has become the first in the UK to deploy a digital self-testing system – DigiVis DVA system …
Digital Control Room, a major pharma provider, wins King’s Award for Enterprise
May 7, 2025Business Services, Medical Communications Digital Control Room, King's Award for Enterprise, Pharma services, Pharmacy, UK
Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online content, will receive a King’s …
Deadly cancers are being financially left behind, new research claims
May 1, 2025Research and Development Jude, Oncology, UK, bladder cancer, cancer research, charitable funding
New research has revealed that some of the UK’s most deadly and prevalent cancers receive the least amount of charitable …
Moderna authorised to upscale development of mRNA vaccines in UK
April 15, 2025Manufacturing and Production Moderna, UK, UK government, Virology, mrna, vaccination
Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …
Levosert® (52mg levonorgestrel intrauterine system [IUS]) receives an 8-year licence extension in the UK for contraception
August 5, 2024Research and Development Contraception, UK, contraception, license extension
Gedeon Richter UK Ltd. (“Richter”) today announced that the Medicines Health Regulatory Authority (MHRA) has authorised an extension to the …
Long COVID: 15 studies launched with £19.6 million government funding
July 19, 2021Sales and Marketing NHS, UK, long covid
The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate …
Drugmakers fined a record £260 million after 10,000% drug price increase
July 16, 2021Medical Communications UK
The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma …
New targeted lung cancer treatment coming to UK under MHRA scheme
July 15, 2021MHRA, NSCLC, UK, brexit
The MHRA has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib, for the treatment of …
Summer COVID cases set to reach 2 million with 10 million isolating
July 7, 2021Research and Development COVID-19, Lockdown, UK, Vaccine, government
Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …
Over 600,000 positive COVID tests genomically sequenced in UK
July 5, 2021Sales and Marketing COVID-19, Delta variant, UK, government, variant
The UK has genomically sequenced more than 600,000 positive COVID-19 test, it was announced on Friday. Genomic sequencing plays a …
Survey reveals over 2 million people impacted by long COVID in UK
June 24, 2021COVID-19, UK, government, long covid, study
A recent survey from Imperial College London has revealed that over 2 million people in the UK may have suffered …
UK COVID vaccine update
June 16, 2021Research and Development COVID-19, UK, care homes, children, government, vaccines
Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …
Ground-breaking COVID antibody treatment proven to save lives
June 16, 2021Research and Development COVID-19, UK, antibodies, trial
Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …
G7: UK to donate 100 million surplus vaccine doses
June 11, 2021Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine
Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …
NICE recommends Janssen’s active psoriatic arthritis drug
May 28, 2021Medical Communications Janssen, NICE, UK, arthritis
NICE have released a Final Appraisal Document (FAD) recommending Janssen’s tremfya (guselkumab) as a new option for treating active psoriatic …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
